Inhalations of Ultra-low Doses of Melphalan for the Treatment of Non-cystic Fibrosis Bronchiectasis
Condition(s):Non-cystic Fibrosis BronchiectasisLast Updated:February 20, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Non-cystic Fibrosis BronchiectasisLast Updated:February 20, 2020Unknown status
Condition(s):Non Cystic Fibrosis BronchiectasisLast Updated:December 29, 2023Terminated
Condition(s):Non-cystic Fibrosis BronchiectasisLast Updated:February 29, 2024Not yet recruiting
Condition(s):Non-cystic Fibrosis BronchiectasisLast Updated:January 24, 2024Active, not recruiting
Condition(s):Non-cystic Fibrosis Bronchiectasis (NCFBE)Last Updated:December 7, 2022Recruiting
Condition(s):Non-cystic Fibrosis BronchiectasisLast Updated:June 5, 2023Recruiting
Condition(s):Non-Cystic Fibrosis BronchiectasisLast Updated:February 21, 2024Available
Condition(s):Non-cystic Fibrosis Bronchiectasis; HealthyLast Updated:February 20, 2013Completed
Condition(s):Non-cystic Fibrosis BronchiectasisLast Updated:December 20, 2023Not yet recruiting
Condition(s):Non-Cystic Fibrosis BronchiectasisLast Updated:April 24, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.